ArticleOpen forum infectious diseases2018
Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum.
Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 26 citations in OpenAlex.
- Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).Scientific reports · 2024Trial
- Performance evaluation of NeuMoDx 96 system for hepatitis B and C viral load.World journal of virology · 2023Article
- Observational
- Article
- A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: the '2for1' project.BMC medical education · 2022Article
- Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.Archives of microbiology · 2021Article
- Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis.PLoS medicine · 2021Article
- Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, China.PloS one · 2021Article
- Telemedicine successfully engages marginalized rural hepatitis C patients in curative care.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2020Article
- In-field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in Tanzania.Liver international : official journal of the International Association for the Study of the Liver · 2020Article
- Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis.The Lancet. Global health · 2020Article
- Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model.Lancet (London, England) · 2019Article
- Hepatitis C services at harm reduction centres in the European Union: a 28-country survey.Harm reduction journal · 2019Article
- The Massachusetts Hepatitis C Testing Cascade, 2014-2016.Microbiology insights · 2019Article
- Update on global epidemiology of viral hepatitis and preventive strategies.World journal of clinical cases · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 8 institutions in 4 countries.
Funding
Abstract
A recent international workshop, organized by the authors, analyzed the obstacles facing the ambitious goal of eliminating viral hepatitis globally. We identified several policy areas critical to reaching elimination targets. These include providing hepatitis B birth-dose vaccination to all infants within 24 hours of birth, preventing the transmission of blood-borne viruses through the expansion of national hemovigilance schemes, implementing the lessons learned from the HIV epidemic regarding safe medical practices to eliminate iatrogenic infection, adopting point-of-care testing to improve coverage of diagnosis, and providing free or affordable hepatitis C treatment to all. We introduce Egypt as a case study for rapid testing and treatment scale-up: this country offers valuable insights to policy makers internationally, not only regarding how hepatitis C interventions can be expeditiously scaled-up, but also as a guide for how to tackle the problems encountered with such ambitious testing and treatment programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.